nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—Blood bilirubin increased—Alitretinoin—peripheral nervous system neoplasm	0.00916	0.00916	CcSEcCtD
Cefotetan—Haemolytic anaemia—Melphalan—peripheral nervous system neoplasm	0.00908	0.00908	CcSEcCtD
Cefotetan—Aplastic anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00878	0.00878	CcSEcCtD
Cefotetan—Prothrombin level increased—Doxorubicin—peripheral nervous system neoplasm	0.00855	0.00855	CcSEcCtD
Cefotetan—Colitis—Alitretinoin—peripheral nervous system neoplasm	0.00832	0.00832	CcSEcCtD
Cefotetan—Phlebitis—Dactinomycin—peripheral nervous system neoplasm	0.00788	0.00788	CcSEcCtD
Cefotetan—Vaginal moniliasis—Epirubicin—peripheral nervous system neoplasm	0.00752	0.00752	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Tretinoin—peripheral nervous system neoplasm	0.00748	0.00748	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Isotretinoin—peripheral nervous system neoplasm	0.00748	0.00748	CcSEcCtD
Cefotetan—Phlebitis—Alitretinoin—peripheral nervous system neoplasm	0.0073	0.0073	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Epirubicin—peripheral nervous system neoplasm	0.00721	0.00721	CcSEcCtD
Cefotetan—Vaginal moniliasis—Doxorubicin—peripheral nervous system neoplasm	0.00695	0.00695	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Epirubicin—peripheral nervous system neoplasm	0.00694	0.00694	CcSEcCtD
Cefotetan—Pancytopenia—Topotecan—peripheral nervous system neoplasm	0.00687	0.00687	CcSEcCtD
Cefotetan—Neutropenia—Topotecan—peripheral nervous system neoplasm	0.00676	0.00676	CcSEcCtD
Cefotetan—Pancytopenia—Melphalan—peripheral nervous system neoplasm	0.00673	0.00673	CcSEcCtD
Cefotetan—Neutropenia—Tretinoin—peripheral nervous system neoplasm	0.00671	0.00671	CcSEcCtD
Cefotetan—Neutropenia—Isotretinoin—peripheral nervous system neoplasm	0.00671	0.00671	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Doxorubicin—peripheral nervous system neoplasm	0.00667	0.00667	CcSEcCtD
Cefotetan—Neutropenia—Melphalan—peripheral nervous system neoplasm	0.00662	0.00662	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Doxorubicin—peripheral nervous system neoplasm	0.00642	0.00642	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Tretinoin—peripheral nervous system neoplasm	0.00634	0.00634	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Isotretinoin—peripheral nervous system neoplasm	0.00634	0.00634	CcSEcCtD
Cefotetan—Phlebitis—Cisplatin—peripheral nervous system neoplasm	0.00622	0.00622	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Dactinomycin—peripheral nervous system neoplasm	0.00611	0.00611	CcSEcCtD
Cefotetan—Thrombocytosis—Epirubicin—peripheral nervous system neoplasm	0.0061	0.0061	CcSEcCtD
Cefotetan—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.00597	0.00597	CcSEcCtD
Cefotetan—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.00597	0.00597	CcSEcCtD
Cefotetan—Haemolytic anaemia—Cisplatin—peripheral nervous system neoplasm	0.00594	0.00594	CcSEcCtD
Cefotetan—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.00582	0.00582	CcSEcCtD
Cefotetan—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.00579	0.00579	CcSEcCtD
Cefotetan—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.00577	0.00577	CcSEcCtD
Cefotetan—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.00577	0.00577	CcSEcCtD
Cefotetan—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.00574	0.00574	CcSEcCtD
Cefotetan—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.00574	0.00574	CcSEcCtD
Cefotetan—Phlebitis—Etoposide—peripheral nervous system neoplasm	0.0057	0.0057	CcSEcCtD
Cefotetan—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.0057	0.0057	CcSEcCtD
Cefotetan—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.00567	0.00567	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Alitretinoin—peripheral nervous system neoplasm	0.00567	0.00567	CcSEcCtD
Cefotetan—Thrombocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00564	0.00564	CcSEcCtD
Cefotetan—Pancytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00557	0.00557	CcSEcCtD
Cefotetan—Neutropenia—Dactinomycin—peripheral nervous system neoplasm	0.00548	0.00548	CcSEcCtD
Cefotetan—Erythema multiforme—Tretinoin—peripheral nervous system neoplasm	0.00543	0.00543	CcSEcCtD
Cefotetan—Erythema multiforme—Isotretinoin—peripheral nervous system neoplasm	0.00543	0.00543	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Dactinomycin—peripheral nervous system neoplasm	0.00518	0.00518	CcSEcCtD
Cefotetan—Neutropenia—Alitretinoin—peripheral nervous system neoplasm	0.00509	0.00509	CcSEcCtD
Cefotetan—Pancytopenia—Vincristine—peripheral nervous system neoplasm	0.00498	0.00498	CcSEcCtD
Cefotetan—Neutropenia—Vincristine—peripheral nervous system neoplasm	0.0049	0.0049	CcSEcCtD
Cefotetan—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.00488	0.00488	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Alitretinoin—peripheral nervous system neoplasm	0.00481	0.00481	CcSEcCtD
Cefotetan—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00452	0.00452	CcSEcCtD
Cefotetan—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00451	0.00451	CcSEcCtD
Cefotetan—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.00444	0.00444	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Etoposide—peripheral nervous system neoplasm	0.00442	0.00442	CcSEcCtD
Cefotetan—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00442	0.00442	CcSEcCtD
Cefotetan—Pancytopenia—Cisplatin—peripheral nervous system neoplasm	0.0044	0.0044	CcSEcCtD
Cefotetan—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.00437	0.00437	CcSEcCtD
Cefotetan—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00435	0.00435	CcSEcCtD
Cefotetan—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.00433	0.00433	CcSEcCtD
Cefotetan—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00433	0.00433	CcSEcCtD
Cefotetan—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00428	0.00428	CcSEcCtD
Cefotetan—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00424	0.00424	CcSEcCtD
Cefotetan—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.00421	0.00421	CcSEcCtD
Cefotetan—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00421	0.00421	CcSEcCtD
Cefotetan—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00412	0.00412	CcSEcCtD
Cefotetan—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00411	0.00411	CcSEcCtD
Cefotetan—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00408	0.00408	CcSEcCtD
Cefotetan—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00408	0.00408	CcSEcCtD
Cefotetan—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.00403	0.00403	CcSEcCtD
Cefotetan—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00403	0.00403	CcSEcCtD
Cefotetan—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00403	0.00403	CcSEcCtD
Cefotetan—Blood bilirubin increased—Epirubicin—peripheral nervous system neoplasm	0.00401	0.00401	CcSEcCtD
Cefotetan—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Cefotetan—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Cefotetan—Neutropenia—Etoposide—peripheral nervous system neoplasm	0.00397	0.00397	CcSEcCtD
Cefotetan—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00394	0.00394	CcSEcCtD
Cefotetan—Vaginal inflammation—Epirubicin—peripheral nervous system neoplasm	0.00379	0.00379	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.00375	0.00375	CcSEcCtD
Cefotetan—Blood bilirubin increased—Doxorubicin—peripheral nervous system neoplasm	0.00371	0.00371	CcSEcCtD
Cefotetan—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00366	0.00366	CcSEcCtD
Cefotetan—Colitis—Epirubicin—peripheral nervous system neoplasm	0.00364	0.00364	CcSEcCtD
Cefotetan—Vaginal infection—Epirubicin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Cefotetan—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Cefotetan—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00353	0.00353	CcSEcCtD
Cefotetan—Vaginal inflammation—Doxorubicin—peripheral nervous system neoplasm	0.00351	0.00351	CcSEcCtD
Cefotetan—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00344	0.00344	CcSEcCtD
Cefotetan—Colitis—Doxorubicin—peripheral nervous system neoplasm	0.00337	0.00337	CcSEcCtD
Cefotetan—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00336	0.00336	CcSEcCtD
Cefotetan—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Cefotetan—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Cefotetan—Vaginal infection—Doxorubicin—peripheral nervous system neoplasm	0.00331	0.00331	CcSEcCtD
Cefotetan—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00329	0.00329	CcSEcCtD
Cefotetan—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Cefotetan—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Cefotetan—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Cefotetan—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Cefotetan—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00325	0.00325	CcSEcCtD
Cefotetan—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00325	0.00325	CcSEcCtD
Cefotetan—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00324	0.00324	CcSEcCtD
Cefotetan—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00324	0.00324	CcSEcCtD
Cefotetan—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Cefotetan—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Cefotetan—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Cefotetan—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Cefotetan—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Cefotetan—Urticaria—Melphalan—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Cefotetan—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Cefotetan—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00319	0.00319	CcSEcCtD
Cefotetan—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Cefotetan—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00315	0.00315	CcSEcCtD
Cefotetan—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Cefotetan—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00303	0.00303	CcSEcCtD
Cefotetan—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00303	0.00303	CcSEcCtD
Cefotetan—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Cefotetan—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Cefotetan—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Cefotetan—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Cefotetan—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00296	0.00296	CcSEcCtD
Cefotetan—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00292	0.00292	CcSEcCtD
Cefotetan—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00291	0.00291	CcSEcCtD
Cefotetan—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00291	0.00291	CcSEcCtD
Cefotetan—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00289	0.00289	CcSEcCtD
Cefotetan—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00289	0.00289	CcSEcCtD
Cefotetan—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00289	0.00289	CcSEcCtD
Cefotetan—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Cefotetan—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Cefotetan—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Cefotetan—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Cefotetan—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Cefotetan—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Cefotetan—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Cefotetan—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Cefotetan—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Cefotetan—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Cefotetan—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Cefotetan—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Cefotetan—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Cefotetan—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Cefotetan—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Cefotetan—Rash—Topotecan—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Cefotetan—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Cefotetan—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00258	0.00258	CcSEcCtD
Cefotetan—Rash—Tretinoin—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Cefotetan—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Cefotetan—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Cefotetan—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Cefotetan—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Cefotetan—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Cefotetan—Rash—Melphalan—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Cefotetan—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Cefotetan—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00253	0.00253	CcSEcCtD
Cefotetan—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00249	0.00249	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Cefotetan—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Cefotetan—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Cefotetan—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Cefotetan—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Cefotetan—Nausea—Topotecan—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Cefotetan—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Cefotetan—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Cefotetan—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Cefotetan—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Cefotetan—Nausea—Melphalan—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Cefotetan—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Cefotetan—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Cefotetan—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Cefotetan—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Cefotetan—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Cefotetan—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Cefotetan—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Cefotetan—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Cefotetan—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Cefotetan—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00219	0.00219	CcSEcCtD
Cefotetan—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Cefotetan—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Cefotetan—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Cefotetan—Rash—Dactinomycin—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Cefotetan—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Cefotetan—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Cefotetan—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Cefotetan—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Cefotetan—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Cefotetan—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Cefotetan—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Cefotetan—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00197	0.00197	CcSEcCtD
Cefotetan—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Cefotetan—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Cefotetan—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Cefotetan—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Cefotetan—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Cefotetan—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Cefotetan—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Cefotetan—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Cefotetan—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00189	0.00189	CcSEcCtD
Cefotetan—Rash—Vincristine—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Cefotetan—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Cefotetan—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Cefotetan—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Cefotetan—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Cefotetan—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Cefotetan—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Cefotetan—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Cefotetan—Nausea—Vincristine—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Cefotetan—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Cefotetan—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Cefotetan—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00168	0.00168	CcSEcCtD
Cefotetan—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Cefotetan—Rash—Cisplatin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Cefotetan—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Cefotetan—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Cefotetan—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Cefotetan—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Cefotetan—Rash—Etoposide—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Cefotetan—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00152	0.00152	CcSEcCtD
Cefotetan—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00148	CcSEcCtD
Cefotetan—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Cefotetan—Nausea—Etoposide—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Cefotetan—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Cefotetan—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Cefotetan—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Cefotetan—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Cefotetan—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Cefotetan—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Cefotetan—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Cefotetan—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Cefotetan—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Cefotetan—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Cefotetan—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Cefotetan—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Cefotetan—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Cefotetan—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000997	0.000997	CcSEcCtD
Cefotetan—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000995	0.000995	CcSEcCtD
Cefotetan—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00099	0.00099	CcSEcCtD
Cefotetan—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00099	0.00099	CcSEcCtD
Cefotetan—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000957	0.000957	CcSEcCtD
Cefotetan—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000926	0.000926	CcSEcCtD
Cefotetan—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000922	0.000922	CcSEcCtD
Cefotetan—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000886	0.000886	CcSEcCtD
Cefotetan—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00086	0.00086	CcSEcCtD
Cefotetan—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000857	0.000857	CcSEcCtD
Cefotetan—Rash—Epirubicin—peripheral nervous system neoplasm	0.000853	0.000853	CcSEcCtD
Cefotetan—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000852	0.000852	CcSEcCtD
Cefotetan—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000804	0.000804	CcSEcCtD
Cefotetan—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000796	0.000796	CcSEcCtD
Cefotetan—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000789	0.000789	CcSEcCtD
Cefotetan—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000789	0.000789	CcSEcCtD
Cefotetan—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000744	0.000744	CcSEcCtD
